Your browser doesn't support javascript.
loading
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?
Corianò, Matilde; Giannarelli, Diana; Scartabellati, Giulia; De Giorgi, Ugo; Brighi, Nicole; Fornarini, Giuseppe; Tommasi, Chiara; Giudice, Giulia Claire; Rebuzzi, Sara Elena; Puglisi, Silvia; Caffo, Orazio; Kinspergher, Stefania; Mennitto, Alessia; Cattrini, Carlo; Santoni, Matteo; Verzoni, Elena; Rametta, Alessandro; Stellato, Marco; Malgeri, Andrea; Roviello, Giandomenico; Brunelli, Matteo; Signori, Alessio; Banna, Giuseppe Luigi; Buti, Sebastiano.
Afiliación
  • Corianò M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Giannarelli D; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Scartabellati G; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy.
  • De Giorgi U; Facility of Epidemiology, & Biostatistic, G-STeP Generator, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
  • Brighi N; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Fornarini G; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Tommasi C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Giudice GC; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Rebuzzi SE; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Puglisi S; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Caffo O; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy.
  • Kinspergher S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Mennitto A; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Cattrini C; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.
  • Santoni M; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova, Italy.
  • Verzoni E; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Rametta A; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy.
  • Stellato M; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy.
  • Malgeri A; Division of Oncology, University Hospital "Maggiore della Carità", Novara, Italy.
  • Roviello G; Division of Oncology, University Hospital "Maggiore della Carità", Novara, Italy.
  • Brunelli M; Oncology Unit, Macerata Hospital, Macerata, Italy.
  • Signori A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Banna GL; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Buti S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Expert Rev Anticancer Ther ; 23(5): 545-554, 2023 05.
Article en En | MEDLINE | ID: mdl-37017710

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Expert Rev Anticancer Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Expert Rev Anticancer Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido